Medtronic's Symplicity Spyral RDN system shows sustained BP reduction

By Yahoo! Finance | Oct 29, 2024 at 06:33 AM EST

Medtronic's SPYRAL HTN-ON MED trial showed significant blood pressure reduction with the Symplicity Spyral renal denervation system. Two-year data revealed lasting results, leading to plans for further research on multi-organ denervation for uncontrolled hypertension.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.